Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
Revenues | 1,862.8 | 2,124.0 | 2,042.5 | 1,836.8 | 1,780.7 |
Revenue growth | -12.3% | 4.0% | 11.2% | 3.1% | |
Cost of goods sold | 1,550.3 | 1,797.7 | 1,746.1 | 1,671.6 | 1,670.5 |
Gross profit | 312.5 | 326.3 | 296.4 | 165.2 | 110.3 |
Gross margin | 16.8% | 15.4% | 14.5% | 9.0% | 6.2% |
Selling, general and administrative | 261.8 | 318.9 | 147.1 | 121.4 | 114.9 |
Sales and marketing | 41.1 | 32.8 | 31.3 | 22.7 | 19.2 |
Research and development | 40.8 | 34.2 | 15.1 | 10.3 | |
EBIT | 6.3 | -29.6 | 131.9 | 29.4 | -9.7 |
EBIT margin | 0.3% | -1.4% | 6.5% | 1.6% | -0.5% |
Pre-tax income | 6.6 | -26.3 | 132.4 | 30.8 | -0.8 |
Income taxes | 7.0 | 13.1 | 29.9 | 7.7 | -0.6 |
Tax rate | 106.1% | | 22.6% | 25.0% | 80.1% |
Earnings from continuing ops | -0.4 | -39.4 | 102.5 | 23.1 | -0.2 |
Earnings from discontinued ops | | | | | 0.0 |
Net income | -0.4 | -39.4 | 102.5 | 23.1 | -0.2 |
Net margin | 0.0% | -1.9% | 5.0% | 1.3% | 0.0% |
|
Diluted EPS | $0.00 | ($0.22) | $0.70 | $0.16 | $0.00 |
Shares outstanding (diluted) | 193.1 | 175.5 | 147.0 | 147.1 | 138.0 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|